Literature DB >> 6329562

Renal agenesis as a diagnostic feature of the cryptophthalmos-syndactyly syndrome.

I W Lurie, E D Cherstvoy.   

Abstract

Four families with the cryptophthalmos-syndactyly syndrome are reported. Nine affected patients died in perinatal period. Autopsy, performed in 6 cases, revealed renal agenesis (bilateral in 3 and unilateral in 3 cases). These observations together with recent literature data suggest that renal malformations (agenesis or severe hypoplasia) are one of the most common features of the cryptophthalmos-syndactyly syndrome and may serve as one of diagnostic criteria for this entity.

Entities:  

Mesh:

Year:  1984        PMID: 6329562     DOI: 10.1111/j.1399-0004.1984.tb00496.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  5 in total

Review 1.  The clinical spectrum of the Fraser syndrome: report of three new cases and review.

Authors:  J Gattuso; M A Patton; M Baraitser
Journal:  J Med Genet       Date:  1987-09       Impact factor: 6.318

2.  Cryptophthalmos: surgical treatment of the congenital symblepharon variant.

Authors:  D J Brazier; S J Hardman-Lea; J R Collin
Journal:  Br J Ophthalmol       Date:  1986-05       Impact factor: 4.638

Review 3.  Rehabilitation of a child with partial unilateral cryptophthalmos and multiple congenital anomalies.

Authors:  H Konrad; J C Merriam; I S Jones
Journal:  Trans Am Ophthalmol Soc       Date:  1995

4.  A human gene homologous to the formin gene residing at the murine limb deformity locus: chromosomal location and RFLPs.

Authors:  R L Maas; L I Jepeal; S L Elfering; R F Holcombe; C C Morton; R L Eddy; M G Byers; T B Shows; P Leder
Journal:  Am J Hum Genet       Date:  1991-04       Impact factor: 11.025

Review 5.  Fraser syndrome and cryptophthalmos: review of the diagnostic criteria and evidence for phenotypic modules in complex malformation syndromes.

Authors:  A M Slavotinek; C J Tifft
Journal:  J Med Genet       Date:  2002-09       Impact factor: 6.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.